SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Phage Biotechnology Corp. Engages The Bruckner Group to Find a Joint Commercialization Partner for Phage's Portfolio of Recombinant Protein Biopharmaceuticals, Technologies, and Development Platforms